PET/MR Radiation Safety: Hot Lab Meets the Magnet

A combined PET/MR suite is not one hazard with one rulebook — it is two independent hazard domains sharing a single room, each governed by a different regulator and a different safety program. On the ionizing side, positron-emitting tracers such as F-18 and Ga-68 emit 511 keV annihilation photons and create staff-dose, contamination, and radioactive-waste risks controlled by the NRC or an Agreement State under 10 CFR Parts 20 and 35. On the non-ionizing side, an always-on magnet creates projectile, radiofrequency (RF), gradient, and quench hazards that no radiation regulation touches — those are governed by ACR MR accreditation, the Joint Commission, and MR equipment standards. A defensible PET/MR program runs both an RSO-led radiation-safety program and an MRMD/MRSO/MRSE-led MR-safety program, and reconciles the hot-lab workflow with the ACR four-zone model so the two never work against each other.

Introduction

Simultaneous PET/MR combines the metabolic sensitivity of positron emission tomography with the soft-tissue contrast and lower ionizing-radiation burden of MRI. Clinically that is a powerful pairing, and one reason PET/MR has moved from research into routine oncologic, neurologic, and cardiac imaging. ³⁵ From a facility-safety standpoint, though, the combination does something unusual: it places a radioactive-material workflow and a high-field magnet in the same suite, and asks one department to run two safety programs that come from completely different regulatory worlds.

The temptation is to treat a PET/MR suite as "a PET/CT suite with a magnet instead of a CT," or as "an MRI suite that happens to inject tracer." Both framings are wrong, and both create gaps. A PET/CT program is built around the ionizing side and has no concept of a projectile hazard, spatial-gradient limits, or a quench. An MR-safety program is built around the magnet and has no concept of an authorized user, a written directive, decay-in-storage, or contamination surveys. Neither program, by itself, is complete for a PET/MR suite. ⁴⁶

This article maps the two hazard domains, shows where they physically collide — most sharply at the boundary between the hot-lab/uptake workflow and the ACR four-zone MR model — and lays out how to govern the suite with two coordinated programs rather than one overstretched one. It builds on our existing guides to the MRI safety program, PET/CT shielding, occupational dose from 511 keV sources, and nuclear medicine hot-lab design; this piece is about the integration problem those individual programs do not, on their own, solve.

Topic Explanation

What "PET/MR radiation safety" actually means

PET/MR radiation safety is the coordinated management of two unrelated hazard domains — an ionizing radioactive-material hazard and a non-ionizing electromagnetic hazard — that share the same suite, staff, and patient pathway. The phrase is slightly misleading, because only one of the two domains involves "radiation" in the regulatory sense. It is worth being precise about which is which, because the regulator, the controls, and the responsible people are different for each.

The ionizing / radioactive-material domain is everything associated with the PET tracer: receiving and assaying unit doses in the hot lab, drawing and injecting activity, the uptake period, the injected patient as a distributed 511 keV source, staff external dose, potential contamination from spills or patient body fluids, and radioactive-waste handling and decay-in-storage. This domain is byproduct material and is regulated by the NRC or an Agreement State under 10 CFR Part 20 (radiation protection standards and dose limits) and 10 CFR Part 35 (medical use), with program-specific licensing guidance in NUREG-1556 Volume 9. ⁹¹⁰¹¹

The non-ionizing / MR domain is everything associated with the magnet: the always-on static field (B0) and its projectile and torque effects, RF power deposition quantified as specific absorption rate (SAR), rapidly switched gradients (dB/dt) with their peripheral-nerve-stimulation and acoustic-noise effects, and the cryogen quench. None of these are regulated by NRC or state radiation-machine rules. They are governed by the ACR Manual on MR Safety, ACR MR accreditation, the Joint Commission, and the MR equipment standard IEC 60601-2-33. ⁴⁶⁷⁸

Why the two domains do not share a rulebook

It helps to remember that "radiation" in radiation-safety law means ionizing radiation — radiation energetic enough to strip electrons and damage DNA. The 511 keV photons from positron annihilation qualify. The magnet's static field, RF, and gradients do not; they are non-ionizing electromagnetic fields, more analogous in regulatory terms to ultrasound than to X-rays. That single physical distinction is why a PET/MR suite falls under two entirely separate compliance regimes and cannot be governed by one program or one officer. For the ionizing side the authority is the NRC or Agreement State radioactive-material license; for the magnet the binding authorities are ACR accreditation and the Joint Commission. ⁴⁹

For deeper background on the individual pieces, our MRI safety program guide covers the ACR four-zone model and the MR roles in detail, our 511 keV occupational-dose guide covers PET staff dose, and our MRI SAR and RF safety guide covers RF power deposition. This article assumes those foundations and focuses on the seam where they meet.

Key Technical Principles

The two hazard domains, side by side

The clearest way to see why a PET/MR suite needs two programs is to lay the domains out against the same set of questions: what is the hazard, who governs it, how is it controlled, and who owns it.

The two columns almost never overlap, which is the whole point: a control that manages one column does nothing for the other. A lead syringe shield does not stop a projectile; a ferromagnetic-detection portal does not reduce 511 keV dose. That is why the governance has to be genuinely dual, not a single checklist with an "MR section" bolted on.

Worked example: 511 keV staff dose rate near an injected patient

The 511 keV field around an injected patient is what makes the timing of MR coil placement a radiation-safety decision, not just an MR one. AAPM Task Group 108 gives an effective dose-rate constant for F-18 in a patient of $\Gamma =0.092\mu \text{Sv}{\text{m}}^2{\text{MBq}}^{-1}{\text{h}}^{-1}$. ¹ For a patient injected with a realistic $A=370\text{MBq}$ (10 mCi) of F-18 FDG, the unshielded dose rate at a distance $d$ from the patient follows the inverse-square law:

At arm's length from the patient during coil placement, take $d=1\text{m}$:

Now move in to the close contact that positioning and coil placement actually require, $d=0.3\text{m}$:

Because the injected patient is a distributed source rather than a true point, this inverse-square value is a conservative upper bound at such close range — a measured dose rate at thirty centimeters is lower — but it correctly captures the steep gradient. The dose rate climbs sharply as staff move in, which is exactly why how long and how close staff work on an injected patient dominates their PET dose. This is not academic: a single-department study measured whole-body dose to technologists at roughly twice the value per injected MBq for PET/MR compared with PET/CT (about 10.3 versus 4.7 nSv per injected MBq), and attributed the difference specifically to the longer hands-on contact required to position the patient and place MR coils. ³ Ga-68 emits a comparable 511 keV annihilation field per decay and is typically administered at lower activity than an F-18 FDG dose, so this F-18 estimate is a reasonable upper bound for a Ga-68 workflow at the same distance. ¹²

The collision point: hot-lab workflow versus the four-zone model

The ACR MR-safety model divides the suite into four zones of increasing control: Zone I (free public access), Zone II (the supervised screening interface), Zone III (restricted, supervised only by Level 2 MR personnel), and Zone IV (the magnet room itself, always inside Zone III). The single most important line is the Zone II/III boundary, which should never be crossed without screening and supervision. ⁴ A nuclear-medicine hot-lab workflow, by contrast, is built around a shielded room where doses are assayed, drawn, and injected, plus an uptake room where the patient rests during tracer uptake — none of which the ACR zone model contemplates.

Bolting these together naively produces a workflow that crosses the Zone III/IV boundary repeatedly: draw the dose in the hot lab, cross into the magnet area, realize the patient needs uptake time, cross back out, then cross in again to scan. Every crossing is a screening and access-control event, and every unnecessary crossing is a chance for a ferromagnetic hot-lab item — a syringe shield, a survey meter, a waste cart — to be carried toward the magnet. The design fix is to place the hot lab, dose administration, and uptake room in Zone I/II space, outside the controlled MR boundary, so the injected, screened patient makes a single supervised transition across the Zone II/III boundary into Zone IV. ⁴ Equally important, any instrument that must operate inside the fringe field — a dose calibrator check, a survey meter, syringe shields near the bore — must be MR Safe or MR Conditional and used within its labeled conditions, or kept outside the fringe field entirely.

Clinical Impact

The integration problem is not abstract; it shows up in day-to-day operations. Patient throughput suffers when the workflow forces repeated zone crossings, because each crossing is a controlled event that cannot be rushed. Designing uptake outside the MR access boundary is as much an efficiency decision as a safety one.

Staff dose is the clearest clinical impact. Because MR coil placement and patient positioning demand close, hands-on contact with an injected patient, PET/MR concentrates staff exposure into exactly the geometry the worked example above shows to be worst — short distance, meaningful time. The measured doubling of per-MBq technologist dose relative to PET/CT is a direct consequence, and it is manageable only if the MR-positioning step is treated as a radiation-protection task, with pre-staged coils, rehearsed positioning, and minimized hands-on time. ³

Emergency response becomes genuinely cross-domain. A contamination spill in the magnet room must be cleaned up with MR-safe, non-ferromagnetic materials by people who are also MR-screened. A medical emergency requires moving the patient out of Zone IV before certain interventions, while also accounting for the injected activity. A quench — a sudden boil-off of cryogen — is an oxygen-displacement asphyxiation hazard that the RSO's radiation-emergency plan never anticipated, and it has to be drilled by staff who may be focused on the tracer. No single-domain emergency plan covers these; the two plans have to be written to interlock.

Practical Optimization Tips

• Design uptake outside the MR access boundary. Put the hot lab, injection, and uptake room in Zone I/II so the injected patient crosses the Zone II/III line once, under supervision, rather than shuttling across it. Solve this on the floor plan before construction. ⁴
• Specify MR Safe / MR Conditional hot-lab equipment near the magnet. Dose calibrators, survey meters, syringe and vial shields, waste containers, carts, and step stools used inside the fringe field must be labeled MR Safe or MR Conditional and used within their stated conditions. Keep ferromagnetic items outside the 5-gauss line. Ferromagnetic-detection screening should treat radiation-shielded objects as suspect, since lead shields are often steel-jacketed. ⁴
• Treat positioning as a dose-reduction task. Pre-stage and pre-connect coils, rehearse the position, and minimize hands-on time with the injected patient. Distance is your most powerful lever — the inverse-square dependence means small increases in working distance produce large dose reductions. ¹³
• Screen for both domains at intake. A PET/MR patient needs both an MR safety screen (implants, devices, foreign bodies) and the nuclear-medicine checks (pregnancy/lactation, prior tracer, renal function as applicable). Build a single intake that satisfies both, so nothing is dropped in the handoff between the nuclear-medicine and MR sides. ⁴⁵
• Write one integrated emergency plan. Cover contamination spills in Zone IV with MR-safe cleanup, patient extraction from the magnet for codes, and quench/oxygen-displacement response — and drill it with staff who work both sides.
• Name the roles in writing and make them talk. The RSO and the MRMD/MRSO/MRSE should co-author the suite's policies. A program that names an RSO but no MRSE (or vice versa) has an unowned hazard domain.
• Do not forget attenuation correction interactions. MR-based attenuation correction is its own quantitative-accuracy topic; see our PET/MR attenuation correction guide. It is not a safety issue, but it is part of commissioning the same suite.

Regulatory Considerations

The governance split is the single most important regulatory fact about a PET/MR suite: the two hazard domains answer to two different authorities, and satisfying one does nothing for the other.

On the radioactive-material side, possession and medical use of F-18, Ga-68, and any other positron emitters fall under 10 CFR Part 35 (or the equivalent Agreement State program), with occupational and public dose limits set by 10 CFR Part 20 — 50 mSv/y occupational effective dose and 1 mSv/y to members of the public — and program-specific licensing expectations in NUREG-1556 Volume 9. ⁹¹⁰¹¹ This is the RSO's territory: license conditions, authorized users, written directives where applicable, dose monitoring, surveys, contamination control, and radioactive-waste handling. Hot-lab shielding is evaluated with PET methods such as AAPM TG-108. ¹

On the magnet side, there is no NRC or state radiation license, because the magnet emits no ionizing radiation. The binding authorities are ACR MR accreditation (built on the ACR Manual on MR Safety and the ACR guidance on MR safe practices), the Joint Commission, and, for equipment, IEC 60601-2-33. ⁴⁶⁷⁸ The Joint Commission consolidated its imaging-safety expectations into National Performance Goal #13, "Protecting Patients and Providers in Imaging," effective January 1, 2026, which reinforces MR environmental risk reduction — access restriction, screening, and the four-zone model — as an accreditation expectation. ⁷ MRI also has no MQSA-style federal quality mandate, so the physicist's annual MR equipment performance evaluation is driven by ACR accreditation and Joint Commission standards rather than a radiation statute.

Agreement State nuance. Of the states DRPS serves, Florida, Maryland, Virginia, California, Nevada, Pennsylvania, New York, and New Jersey are NRC Agreement States that license medical use of radioactive material under their own radiation-control programs, while Washington, DC is regulated directly by the NRC. In Florida, the radioactive-material and hot-lab side is administered by the Florida Department of Health, Bureau of Radiation Control under Chapter 64E-5, F.A.C.; the state — not the NRC — licenses, inspects, and receives reports. Critically, the MRI scanner is not covered by that state radiation program, because MRI is non-ionizing; do not attach a 64E-5 citation to the magnet, RF, or quench hazards. Always confirm which authority issues the materials license and which MR accreditation and Joint Commission requirements apply. For related compliance context, see our guide to NRC occupational dose limits under Part 20.

Frequently Asked Questions (FAQs)

Does the NRC regulate the MRI part of a PET/MR suite?

No. The NRC and Agreement States regulate the byproduct material — the F-18 and Ga-68 tracers, the hot lab, staff and public dose, contamination, and radioactive waste — under 10 CFR Parts 20 and 35. The magnet is non-ionizing and falls outside the radiation program entirely; its safety is governed by ACR MR accreditation, the Joint Commission, and MR equipment standards such as IEC 60601-2-33. A PET/MR suite therefore needs two separate programs that share the same room.

Who is responsible for safety in a PET/MR suite?

Responsibility is split. The Radiation Safety Officer (RSO) owns the radioactive-material program: licensing, dose, contamination, surveys, and waste. The MR side is owned by the MR Medical Director (MRMD), the MR Safety Officer (MRSO), and the MR Safety Expert (MRSE, typically a medical physicist). No single role covers both hazard domains, so the two programs must be coordinated in writing.

Can a standard dose calibrator or survey meter be used near the magnet?

Not necessarily. Conventional hot-lab instruments, syringe shields, carts, and waste containers contain ferromagnetic material and become projectile hazards or malfunction inside the static field. Equipment used inside Zone III/IV must be MR Safe or MR Conditional and labeled per its conditions, or the workflow must keep the instrument outside the magnet's fringe field.

How do you inject and let a patient take up tracer without repeatedly crossing the Zone III/IV boundary?

Design the workflow so dose drawing, injection, and uptake happen in a shielded hot lab and uptake room located in Zone I or Zone II, outside the controlled MR access boundary. The screened, injected patient then makes a single, supervised transition across the Zone II/III boundary into the magnet room, rather than shuttling back and forth across it.

Is staff radiation dose higher in PET/MR than in PET/CT?

It can be. A single-department comparison found that, per injected megabecquerel of F-18, whole-body dose to technologists was roughly twice as high for PET/MR as for PET/CT, driven by prolonged close contact with the injected patient during positioning and MR coil placement. Optimizing positioning and minimizing hands-on time near the injected patient are the main mitigations.

Does Florida's radiation program cover the MRI scanner?

No. Florida regulates radioactive material and radiation-producing machines, but MRI is non-ionizing and is not covered by the state radiation-machine program. For a Florida PET/MR suite, the tracer and hot lab fall under the Florida Department of Health, Bureau of Radiation Control (Chapter 64E-5, F.A.C.) as an NRC Agreement State, while the magnet is governed by ACR accreditation and the Joint Commission — not the state radiation program.

When should a facility bring in a medical physicist for a PET/MR project?

Before the suite is designed. Hot-lab shielding, uptake-room placement, patient and staff flow across the four MR zones, MR-conditional equipment selection, and the coordination of the radiation-safety and MR-safety programs are all cheaper to solve on paper than after construction. A physicist can also serve as the MR Safety Expert and support the RSO program.

Key Takeaways

• A PET/MR suite is two hazard domains in one room. The ionizing tracer side and the non-ionizing magnet side have different physics, different regulators, and different controls.
• The regulators do not overlap. NRC/Agreement State rules (10 CFR 20 & 35) govern the tracer and hot lab; ACR accreditation and the Joint Commission govern the magnet. Neither covers the other. ⁴⁹
• The governance is dual. An RSO owns the radioactive-material program; an MRMD/MRSO/MRSE owns the MR-safety program. A suite missing either has an unowned hazard. ⁴
• Reconcile the workflow with the four zones. Put the hot lab, injection, and uptake in Zone I/II so the injected patient crosses the Zone II/III boundary once, and keep ferromagnetic hot-lab equipment out of the fringe field. ⁴
• PET/MR can raise staff dose. Close, prolonged contact during coil placement roughly doubled per-MBq technologist dose versus PET/CT in one study; treat positioning as a dose-reduction task. ³
• In Florida, do not mis-cite the magnet. The tracer side is 64E-5 / Bureau of Radiation Control; the MRI scanner is non-ionizing and outside the state radiation program.

Conclusion

The defining fact about a PET/MR suite is that it stacks two unrelated hazards — ionizing radiation from positron emitters and a powerful, always-on magnetic field — in one workflow, and that each hazard answers to a different regulator and a different safety program. The failure mode is not exotic physics; it is a governance gap, where a strong radiation-safety program assumes it has the magnet covered, or a mature MR-safety program assumes someone else is handling the tracer. A defensible suite closes that gap by running both programs, naming both sets of roles, and designing the physical workflow so the hot-lab process and the ACR four-zone model reinforce each other instead of colliding. Get the floor plan, the equipment specifications, and the two programs right early, and the combined suite is both safe and efficient; retrofit them after construction, and every zone crossing becomes a compromise.

How DRPS Can Help

Diagnostic Radiation Physics Services helps imaging and nuclear medicine facilities plan and operate hybrid suites where the ionizing and non-ionizing programs have to work together. For a PET/MR project, that can include hot-lab and uptake-area shielding design, staff-dose and workflow assessment across the four MR zones, MR Safe / MR Conditional equipment selection, service as the MR Safety Expert (MRSE), and coordination between the RSO program and the MR-safety program so both satisfy their respective authorities. Explore our PET/CT and nuclear medicine physics, MRI physics testing, and Radiation Safety Officer services.

DRPS supports facilities across our service locations, including Florida, Maryland, Virginia, Washington DC, California, Nevada, Pennsylvania, New York, New Jersey, and Delaware.

Related Resources

• MRI safety program: ACR zones and roles
• PET/CT shielding calculations guide
• Occupational dose from 511 keV PET sources
• Nuclear medicine hot-lab design
• PET/MR attenuation correction
• MRI SAR and RF safety
• PET/CT and nuclear medicine physics
• MRI physics testing
• Radiation Safety Officer consulting

References

1. Madsen MT, Anderson JA, Halama JR, et al. AAPM Task Group 108: PET and PET/CT shielding requirements. Medical Physics. 2006;33(1):4-15. doi:10.1118/1.2135911. aapm.onlinelibrary.wiley.com
2. Smith DS, Stabin MG. Exposure rate constants and lead shielding values for over 1,100 radionuclides. Health Physics. 2012;102(3):271-291. doi:10.1097/HP.0b013e318235153a. PubMed
3. Soret M, Maisonobe JA, Payen S, et al. Radiation dose to nuclear medicine technologists when operating PET/MR compared with PET/CT. Journal of Radiological Protection. 2022;42(2):021517. doi:10.1088/1361-6498/ac5e50. PubMed
4. Kanal E, Barkovich AJ, Bell C, et al. ACR guidance document on MR safe practices: 2013. Journal of Magnetic Resonance Imaging. 2013;37(3):501-530. doi:10.1002/jmri.24011. PubMed
5. Ruddy TD, Al-Mallah M, Arrighi JA, et al. SNMMI/ACR/ASNC/SCMR joint credentialing statement for cardiac PET/MRI. Journal of Nuclear Medicine. 2023;64(1):149-152. doi:10.2967/jnumed.122.264200. PubMed
6. American College of Radiology. ACR Manual on MR Safety (2024 edition). Reston, VA: ACR. acr.org
7. The Joint Commission. National Performance Goal #13: Protecting Patients and Providers in Imaging (effective January 1, 2026). jointcommission.org
8. International Electrotechnical Commission. IEC 60601-2-33: Medical electrical equipment — Part 2-33: Particular requirements for the basic safety and essential performance of magnetic resonance equipment for medical diagnosis. Geneva: IEC. iec.ch
9. U.S. Nuclear Regulatory Commission. 10 CFR Part 20: Standards for Protection Against Radiation. nrc.gov
10. U.S. Nuclear Regulatory Commission. 10 CFR Part 35: Medical Use of Byproduct Material. nrc.gov
11. U.S. Nuclear Regulatory Commission. NUREG-1556, Volume 9, Revision 3: Consolidated Guidance About Materials Licenses — Program-Specific Guidance About Medical Use Licenses. nrc.gov
12. International Commission on Radiological Protection. ICRP Publication 107: Nuclear Decay Data for Dosimetric Calculations. Annals of the ICRP. 2008;38(3). icrp.org